Copyright © 2021 Advocate Law Group P.C. ("Advocate")

All Rights Reserved

Here, let visitors know what will happen when they complete your form.


Free Zantac Case Review

Begin here ...

Please provide me with a free, no obligation case review, and treat my information confidentially within Advocate Law Group P.C. and its Network. 

I accept Advocate's Privacy Policy & Terms of Use.

We’ll do all the work, saving you time, travel, and paperwork, and get you the money you deserve as quickly as possible.

Stress Free

Zantac, Popular Heartburn Medicine, Linked to Cancer 

Advocate Law Group Network Attorneys Currently Reviewing Zantac Lawsuits. To request a free, no-obligation case review for yourself or a loved one, call or fill out the Form today.

You, and the 

Advocate Law Group Network

Together We Win!TM

Call 24/7 for 

Free Case Evaluation 


Hundreds of Millions of Dollars

Won by the attorneys in the Advocate Law Group Network for thousands of clients nationwide. 

Top-Rated Nationwide Network

The power and strength of a top-rated nationwide network. And while we fight hard to win, we treat you, our clients, with the compassion and respect you deserve.

Zantac, Popular Heartburn Medicine, Linked to Cancer 

Advocate Law Attorneys Currently Reviewing Zantac Lawsuits

            Zantac, an antacid drug often used to treat heartburn, has been on the U.S. market since 1983. Zantac became incredibly popular and was one of the first drugs to hit $1 billion a year in sales. Available both over the counter and in prescription strength form, Zantac was marketed as a risk-free drug that could eliminate heartburn, intestinal ulcers, and other serious stomach/intestinal issues.

              While Zantac (also known as ranitidine) was successful in treating heartburn and other stomach conditions, recent studies have revealed it contains extremely high levels of N-Nitrosodimethylamine (NDMA). NDMA is an extremely dangerous carcinogen that has been known to cause cancer since the 1970s. The link between Zantac and NDMA was first made public in 2019 following a Valisure study. Valisure, a pharmacy that performs independent testing on the chemical compositions of various drugs, discovered that Zantac had levels of NDMA that were over 25,000 times the FDA recommended safety level. Soon after these results were released, the FDA performed its own tests confirming that Zantac had unsafe levels of NDMA. In April of 2020, the FDA ordered a full recall for Zantac and all other ranitidine drugs on the market.

              Numerous medical studies, including some published in leading medical journals such as the Journal of the American Medical Association (JAMA), have shined a spotlight on Zantac’s links to NDMA. These studies have demonstrated that the high levels of NDMA found in Zantac are caused by the drug’s interactions with heat and certain chemicals found in the stomach. Evidence also has started to emerge that Sanofi and other drug manufacturers were fully aware that Zantac could contain high levels of cancer-causing NDMA as early as the 1980s.

              If you or a loved one have been diagnosed with cancer after taking Zantac, you may be entitled to compensation for your suffering, medical costs, lost wages, and more.

You or a loved one might qualify if:

               You have been diagnosed with any of the following deadly cancers: bladder cancer, breast cancer,                                colon cancer, esophageal cancer, kidney cancer, liver cancer, ovarian cancer, prostate cancer,                                    stomach cancer, and melanoma.

You have a history of taking Zantac

            Sanofi, Glaxo, and other Zantac Manufacturers ignored Zantac’s links to cancer and marketed their products to consumers for decades, making incredible profits but causing American consumers immeasurable harm. To hold them accountable, call us toll-free or complete the form for a free case review. Our legal team is here to help and will quickly respond to all inquiries.

Have a Question? Call Us Now!